Understanding organ dysfunction in hemophagocytic lymphohistiocytosis

1Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Objective: This review aims to help critical care clinicians maintain a high level of suspicion regarding the diagnosis of Hemophagocytic Histiolymphocytosis (HLH). It describes the clinical and laboratory features of HLH, outlines its pathophysiology and reviews the most frequent etiologies related to HLH. Prognostic factors and therapeutic options are also reported. Data sources: Review of the literature. Results: The diagnosis of HLH relies on the association of clinical abnormalities and hemophagocytosis in bone marrow, spleen, or lymph node specimens. Liver, pulmonary, renal, cardiac and skin involvement may occur at various degrees possibly leading to multiple organ failure. Three main etiologies can be found, namely infections, lymphoproliferative diseases, or connective tissue diseases. Immune deficiency is often retrieved. Mortality can be as high as 50%. Although clinically mimicking severe sepsis, HLH has a distinct pathophysiology on which specific therapy is based. Early diagnosis and treatment is mandatory to increase the chances of survival. Conclusion: The comprehensive management of severe HLH requires the involvement of a multidisciplinary team in order to determine the best therapeutic strategy and to identify the underlying cause.

Cite

CITATION STYLE

APA

Créput, C., Galicier, L., Buyse, S., & Azoulay, E. (2012). Understanding organ dysfunction in hemophagocytic lymphohistiocytosis. In Applied Physiology in Intensive Care Medicine 2: Physiological Reviews and Editorials (pp. 207–217). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-642-28233-1_21

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free